Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001739410-25-000112
Filing Date
2025-08-07
Accepted
2025-08-07 08:33:38
Documents
67
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rlyb-20250630.htm   iXBRL 10-Q 1227396
2 EX-31.1 rlyb-20250630xex311.htm EX-31.1 10287
3 EX-31.2 rlyb-20250630xex312.htm EX-31.2 10276
4 EX-32.1 rlyb-20250630xex321.htm EX-32.1 4845
5 EX-32.2 rlyb-2025630xex322.htm EX-32.2 4826
11 rlyb-20250630_g1.jpg GRAPHIC 8945
  Complete submission text file 0001739410-25-000112.txt   5670097

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlyb-20250630.xsd EX-101.SCH 34828
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rlyb-20250630_cal.xml EX-101.CAL 48934
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rlyb-20250630_def.xml EX-101.DEF 187383
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlyb-20250630_lab.xml EX-101.LAB 542372
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlyb-20250630_pre.xml EX-101.PRE 376776
70 EXTRACTED XBRL INSTANCE DOCUMENT rlyb-20250630_htm.xml XML 571256
Mailing Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510 203- 859-3820
Rallybio Corp (Filer) CIK: 0001739410 (see all company filings)

EIN.: 851083789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40693 | Film No.: 251191807
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)